Spravato

The insurance-backed nasal spray is a promising treatment for individuals suffering from treatment-resistant depression or major depressive disorder with suicidal ideation.

Also called:

Options ~ simplified

Pros & Cons

Your individual experience may vary based on your medical history, genetics, environment, habits, and other factors.

Highly effective for treating TRD and MDSI

Only needs to be administered
1 or 2 times per week

Backed by most insurance

Johnson & Johnson REMS certification supports a safe procedure

Does not cause weight gain like other antidepressants

Needs to be done at a treatment facility

Unable to drive after treatment

Requires 4-6 doses

No generic option

Need to meet the requirements of
trying 2 antidepressants

Immediate relief is realistic

Reduction of depressive symptoms within 24 hours

In a study conducted by Aspire, esketamine was found to decrease the MADRS total score by 4 points on the 18-point scale within a 24-hour period after initial treatment.

Immediate relief
is realistic

Reduction of depressive symptoms within 24 hours

In a study conducted by Aspire, esketamine was found to decrease the MADRS total score by an average of 4 points on the 18-point scale within a 24-hour period of the first treatment.

Common questions

As seen on...

Depression

Transcend the condition that affects 1 in 5 Americans.

Insurance-backed

Getting mental health care has never been easier. Wondering if Spravato is right for you? 

Articles

Subscribe to Psycle to #breakthepsycle

ENTER YOUR EMAIL BELOW TO GET INSIDER UPDATES DELIVERED STRAIGHT TO YOUR INBOX.😌ðŸ§